Clinical trial Recruiting at 1 site Observational Ages 40 to 85

Self-compassion and self-efficacy in Parkinson’s disease and physical disability

Official title: "Associations of Self-Compassion and Self-Efficacy With Symptom Severity, Functional Status, and Quality of Life in Individuals With Parkinson's Disease: A Cross-Sectional Study"

Run by Acibadem University · NCT07488351 · Data updated 2026-11-12

Researchers will see if higher self-compassion and self-efficacy relate to fewer symptoms, better function, and improved quality of life in people with Parkinson’s disease.

Quick facts

Study typeObservational
Ages40 Years to 85 Years
SexAll
Enrollment100 (estimated)
SponsorAcibadem University
Academic / other
Locations1 site (Istanbul, Turkey)
StatusRecruiting
StartedMarch 30, 2026
Main results expectedDecember 30, 2026
Study endsMarch 30, 2027
Registry record updatedJuly 15, 2026
Trial IDNCT07488351 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40–85 with a clinical diagnosis of Parkinson’s disease, Hoehn and Yahr stages 1–3, MMSE ≥24, able to consent and complete questionnaires, attending the movement disorders clinic at Acibadem University.

Probably not a fit

Individuals with advanced dementia, major depressive or psychotic disorders, uncontrolled medical conditions, severe sensory impairments, or inability to cooperate with assessments may not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines how patients’ self-compassion and belief in their own abilities correlate with symptom severity, daily functioning, and overall quality of life in Parkinson’s disease. Participants will complete self-report questionnaires to measure these psychosocial factors and standard assessments to gauge motor and non-motor symptoms. The study will analyze relationships between these factors in patients at Hoehn and Yahr stages 1–3, aged 40–85, with preserved cognitive function. Data collection occurs in a movement disorders outpatient clinic setting at Acibadem University in Istanbul. No experimental intervention is involved beyond questionnaires, and results may inform supportive strategies for managing Parkinson’s disease.

Why it matters

Potential benefit: If associations are found, it could help guide psychosocial support strategies to improve quality of life for people with Parkinson’s disease.

How similar studies have gone: Previous research in Parkinson’s has linked psychosocial factors to quality of life, but this exact self-compassion/self-efficacy focus in this population is relatively novel and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of Parkinson's disease
* Hoehn and Yahr stage 1-3
* Age 40 to 85 years
* Mini-Mental State Examination (MMSE) score ≥24
* Sufficient cognitive function to communicate and complete study assessments
* Attending the Movement Disorders Outpatient Clinic, Department of Neurology
* Able and willing to provide written informed consent

Exclusion Criteria:

* Major depressive disorder or psychotic disorder
* Advanced dementia
* Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension)
* Severe cardiovascular or respiratory disease
* Additional neurological or orthopedic conditions that may affect assessment performance
* Severe visual or hearing impairment that could interfere with study assessments
* Inability to cooperate with the physiotherapist during study assessments

Where it's running

  • Acibadem University
    Istanbul, Turkey, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.